Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
OncoboxPD: human 51 672 molecular pathways database with tools for activity calculating and visualization.
Zolotovskaia MA, Tkachev VS, Guryanova AA, Simonov AM, Raevskiy MM, Efimov VV, Wang Y, Sekacheva MI, Garazha AV, Borisov NM, Kuzmin DV, Sorokin MI, Buzdin AA. Zolotovskaia MA, et al. Among authors: sekacheva mi. Comput Struct Biotechnol J. 2022 May 10;20:2280-2291. doi: 10.1016/j.csbj.2022.05.006. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35615022 Free PMC article.
RNA sequencing for research and diagnostics in clinical oncology.
Buzdin A, Sorokin M, Garazha A, Glusker A, Aleshin A, Poddubskaya E, Sekacheva M, Kim E, Gaifullin N, Giese A, Seryakov A, Rumiantsev P, Moshkovskii S, Moiseev A. Buzdin A, et al. Semin Cancer Biol. 2020 Feb;60:311-323. doi: 10.1016/j.semcancer.2019.07.010. Epub 2019 Aug 11. Semin Cancer Biol. 2020. PMID: 31412295 Review.
Disparity between Inter-Patient Molecular Heterogeneity and Repertoires of Target Drugs Used for Different Types of Cancer in Clinical Oncology.
Zolotovskaia MA, Sorokin MI, Petrov IV, Poddubskaya EV, Moiseev AA, Sekacheva MI, Borisov NM, Tkachev VS, Garazha AV, Kaprin AD, Shegay PV, Giese A, Kim E, Roumiantsev SA, Buzdin AA. Zolotovskaia MA, et al. Among authors: sekacheva mi. Int J Mol Sci. 2020 Feb 26;21(5):1580. doi: 10.3390/ijms21051580. Int J Mol Sci. 2020. PMID: 32111026 Free PMC article.
Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer.
Gudkov A, Shirokorad V, Kashintsev K, Sokov D, Nikitin D, Anisenko A, Borisov N, Sekacheva M, Gaifullin N, Garazha A, Suntsova M, Koroleva E, Buzdin A, Sorokin M. Gudkov A, et al. Front Mol Biosci. 2022 Mar 14;9:753318. doi: 10.3389/fmolb.2022.753318. eCollection 2022. Front Mol Biosci. 2022. PMID: 35359606 Free PMC article.
Clinically relevant fusion oncogenes: detection and practical implications.
Sorokin M, Rabushko E, Rozenberg JM, Mohammad T, Seryakov A, Sekacheva M, Buzdin A. Sorokin M, et al. Ther Adv Med Oncol. 2022 Dec 26;14:17588359221144108. doi: 10.1177/17588359221144108. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36601633 Free PMC article. Review.
Pan-cancer antagonistic inhibition pattern of ATM-driven G2/M checkpoint pathway vs other DNA repair pathways.
Zolotovskaia MA, Modestov AA, Suntsova MV, Rachkova AA, Koroleva EV, Poddubskaya EV, Sekacheva MI, Tkachev VS, Garazha AV, Glusker AA, Seryakov AP, Vladimirova US, Rumiantsev PO, Moisseev AA, Zharkov DO, Kuzmin DV, Zhao X, Prassolov VS, Shegay PV, Li X, Steinbichler TB, Kim E, Sorokin MI, Wang Y, Buzdin AA. Zolotovskaia MA, et al. Among authors: sekacheva mi. DNA Repair (Amst). 2023 Mar;123:103448. doi: 10.1016/j.dnarep.2023.103448. Epub 2023 Jan 13. DNA Repair (Amst). 2023. PMID: 36657260
44 results